Диссертация (1335905), страница 28
Текст из файла (страница 28)
683-92.127. Noussios, G. Ectopic parathyroid glands and their anatomical, clinical andsurgical implications / G. Noussios, P. Anagnostis, K. Natsis // Exp ClinEndocrinol Diabetes. – 2012. – Vol.120, №10. – P. 604-10.128. Okada, M. Tertiary hyperparathyroidism resistant to cinacalcet treatment /M. Okada, Y. Tominaga, K. Izumi, H. Nobata, T. Yamamoto, T.
Hiramitsu, M.Tsujita, N. Goto, K. Nanmoku, T. Watarai, K. Uchida // Ther Apher Dial. –2011. – Vol.15 (Suppl 1). – P. 33-7.129. Oliveira, R.B. Early control of PTH and FGF23 in normophosphatemicCKD patients: a new target in CKD-MBD therapy? / R.B. Oliveira, A.L.Cancela, F.G. Graciolli, L.M. Dos Reis, S.A. Draibe, L. Cuppari, A.B.Carvalho, V. Jorgetti, M.E. Canziani, R.M.
Moysés // Clin J Am Soc Nephrol. –2010. – Vol.5. – P. 286–291.130. Onoda, N. Evaluation of blood supply to the parathyroid glands in secondaryhyperparathyroidism compared with histopathology / N. Onoda, S. Kurihara, Y.Sakurai, K. Owada, E. Osono, H. Adachi, M. Suga, H. Yoneshima // NephrolDial Transplant. - 2003. – Vol.18 (Suppl 3). – P. 34-7.160131. Onoda, N. New clinical guidelines for selective direct injection therapy ofthe parathyroid glands in chronic dialysis patients / Onoda N, Fukagawa M,Tominaga Y, Kitaoka M, Akizawa T, Koiwa F, Kakuta T, Kurokawa K;Japanese Society for Parathyroid Intervention // NDT Plus. - 2008.
– Vol.1(Suppl 3) – P. 26-28.132. Palmer, S.C. Cinacalcet in patients with chronic kidney disease: acumulative meta-analysis of randomized controlled trials / Palmer SC, Nistor I,Craig JC, Pellegrini F, Messa P, Tonelli M, Covic A, Strippoli GF. // PLoS Med- 2013. – Vol.10. - e1001436.133. Palmer, S.C. Trial Quality in Nephrology: How Are We Measuring Up? /S.C. Palmer, M. Sciancalepore, G.F. Strippoli // Am J Kidney Dis.
– 2011. –Vol.58, №3. – P. 335-7.134. Palmer, S.C. Vitamin D compounds for people with chronic kidney diseaserequiring dialysis / S.C. Palmer, D.O. McGregor, J.C. Craig, G. Elder, P.Macaskill, G.F. Strippoli // Cochrane Database Syst Rev. – 2009. – N4 –CD005633.135. Parfrey, P.S. The Effects of Cinacalcet in Older and Younger Patients onHemodialysis: The Evaluation of Cinacalcet HCl Therapy to LowerCardiovascular Events (EVOLVE) Trial / P.S. Parfrey, T.B. Drüeke, G.A.Block, R.
Correa-Rotter, J. Floege, C.A. Herzog, G.M. London, K.W.Mahaffey, S.M. Moe, D.C. Wheeler, Y. Kubo, B. Dehmel, W.G. Goodman,G.M. Chertow // Clin J Am Soc Nephrol. – 2015. – Vol.10, №5. – P. 791-9.136. Qunibi, W.Y. Treatment of hyperphosphatemia in hemodialysis patients:The Calcium Acetate Renagel Evaluation (CARE Study) / W.Y. Qunibi, R.E.Hootkins, L.L. McDowell, M.S. Meyer, M.
Simon, R.O. Garza, R.W. Pelham,M.V. Cleveland, L.R. Muenz, D.Y. He, C.R. Nolan // Kidney Int. – 2004. –Vol.65, №5. – P. 914-26.137. Raggi, P. The ADVANCE study: a randomized study to evaluate the effectsof cinacalcet plus low-dose vitamin D on vascular calcification in patients onhemodialysis/ P. Raggi, G.M. Chertow, P.U.
Torres, B. Csiky, A. Naso, K.161Nossuli, M. Moustafa, W.G. Goodman, N. Lopez, G. Downey, B. Dehmel, J.Floege // Nephrol Dial Transplant. – 2011. – Vol. 26. – P. 1327–1339.138. Razzaque, M.S. Premature aging-like phenotype in fibroblast growth factor23 null mice is a vitamin D-mediated process / M.S. Razzaque, D. Sitara, T.Taguchi, R. St-Arnaud, B. Lanske // FASEB J. – 2006. – Vol.20, №6. – P. 7202.139. Richards, M.L. Parathyroidectomy in secondary hyperparathyroidism: Isthere an optimal operative management? / M.L. Richards, J. Wormuth, J.Bingener, K. Sirinek // Surgery – 2006.
– Vol.139, №2. – P. 174–180.140. Ritz, E. Phosphate additives in food--a health risk / E. Ritz, K.Hahn, M.Ketteler, M.K. Kuhlmann, J. Mann // Dtsch Arztebl Int. – 2012. – Vol.109,№4. – P. 49-55.141. Rodriguez, M. PTH, FGF-23 and early CKD / M. Rodriguez, A.J. Felsenfeld// Nephrol Dial Transplant – 2008. – Vol. 23. – P. 3391–3393.142. Rothmund, M. Subtotal parathyroidectomy versus total parathyroidectomyand autotransplantation in secondary hyperparathyroidism: a randomized trial /M.
Rothmund, P.K. Wagner, Schark C. // World J Surg. – 1991. – Vol.15, № P.745–750.143. Sagliker, Y. Sagliker syndrome: uglifying human face appearance in late andsevere secondary hyperparathyroidism in chronic renal failure / Y. Sagliker, M.Balal, Sagliker P. Ozkaynak, S. Paydas, C. Sagliker, H. Sabit Sagliker, N.Kiralp, S. Mumin Adam, I. Tuncer, G. Gonlusen, M. Esenturk, E. Gocmez, H.Taskapan, M. Yeksan, E. Kobaner, O. Ozkaya, M. Yuksekgonul, I. Emir, N.Cengiz, I. Onder Isik, O. Bilginer, T. Guler, H.
Yakar, N. Sarsmaz, S. Dilaver,B. Akoglu, M. Basgumus, E. Chirik // Semin Nephrol. - 2004. – Vol.24, №5 –P. 449-55.144. Saliba, W. Secondary Hyperparathyroidism: Pathophysiology and Treatment/ W. Saliba, B. El-Haddad // J Am Board Fam Med. – 2009. – Vol.22, №5. – P.574-581.162145. Schlosser,K.Comparisonoftotalparathyroidectomywithoutautotransplantation and without thymectomy versus total parathyroidectomywithautotransplantationandwiththymectomyforsecondaryhyperparathyroidism: TOPAR PILOT-Trial / Schlosser K, Veit JA, Witte S,Fernández ED, Victor N, Knaebel HP, Seiler CM, Rothmund M. // Trials 2007. – Vol.8, №1. – P.
22.146. Schlosser, K. Surgical treatment of tertiary hyperparathyroidism: the choiceof procedure matters! / K. Schlosser, N. Endres, I. Celik, V. Fendrich, M.Rothmund, E.D. Fernandez // World J Surg. - 2007. – Vol.31, №10. – P. 1947–1953.147. Schneider, R. Initial parathyroid surgery in 606 patients with renalhyperparathyroidism / R. Schneider, E.P. Slater, E. Karakas, D.K.
Bartsch, K.Schlosser // World J Surg. – 2012. – Vol.36, №2. – P. 318–326.148. Sharma, J. Improved long-term survival of dialysis patients after near-totalparathyroidectomy / J. Sharma, P. Raggi, N. Kutner, J. Bailey, R. Zhang, Y.Huang, C.A. Herzog, C. Weber // J. Am. Coll. Surg. – 2012. – Vol.214, №4. –P. 400–407.149. Shiizaki, K. Biochemical and Cellular Effects of Direct MaxacalcitolInjection into Parathyroid Gland in Uremic Rats / K. Shiizaki, S. Negi, I.Hatamura, T.
Sakaguchi, F. Saji, K. Kunimoto, M. Mizobuchi, I. Imazeki, A.Ooshima, T. Akizawa // J Am Soc Nephrol. – 2005. – Vol.16, №1. – P. 97-108.150. Shiizaki, K. Direct injection of calcitriol or its analog into hyperplasticparathyroid glands induces apoptosis of parathyroid cells / K. Shiizaki, S. Negi,I. Hatamura, K. Tatsuta, M. Shibata, S. Shimada, T. Sakaguchi, T.
Akizawa //Kidney Int Suppl. – 2006. – Vol.102. – P. 12-5.151. Shimada, T. FGF-23 is a potent regulator of vitamin D metabolism andphosphate homeostasis./ T. Shimada, H. Hasegawa, Y. Yamazaki // J. BoneMiner. Res. – 2004. – Vol.19, №3. – P. 429–35.152. Shinaberger, C.S. Is controlling phosphorus by decreasing dietary proteinintake beneficial or harmful in persons with chronic kidney disease? / C.S.163Shinaberger, S. Greenland, J.D. Kopple, D. Van Wyck, R.
Mehrotra, C.P.Kovesdy, K. Kalantar-Zadeh // Am J Clin Nutr. – 2008. – Vol.88, №6. – P.1511-8.153. Silver J. Phosphate and the parathyroid / J. Silver, T. Naveh-Many // KidneyInt. – 2009. – Vol.75, №9. – P. 898-905.154. Snyder, J. Prevalence of CKD in the United States: a sensitivity analysisusing the National Health and Nutrition Examination Survey (NHANES) 19992004 / JJ Snyder, RN Foley, AJ Collins // Am J Kidney Dis. - 2009. – Vol.53,№2 – P.
218-28.155. Somjen, D. 25-hydroxyvitamin D 3–1alpha-hydroxylase is expressed inhuman vascular smooth muscle cells and is upregulated by parathyroidhormone and estrogenic compounds / Somjen D, Weisman Y, Kohen F, GayerB, Limor R, Sharon O, Jaccard N, Knoll E, Stern N. // Circulation. – 2005. –V.111. – P.1666-1671.156. Sprague, S.M. Paricalcitol versus calcitriol in the treatment of secondaryhyperparathyroidism / S.M. Sprague, F.
Llach, M. Amdahl, C. Taccetta, D.Batlle // Kidney Int. – 2003. – Vol.63, №4 – P. 1483-90.157. Stanbury,S.Electivesubtotalparathyroidectomyforrenalhyperparathyroidism / S. Stanbury, G. Lumb, W. Nicholson // Lancet – 1960. Vol.1(7128). – P. 793–798.158. Stompór, T. Coronary artery calcification in chronic kidney disease: Anupdate / T. Stompór // World J Cardiol. – 2014. - Vol.6, №4. – P. 115-29.159. Sulková, S. Low-dose cholecalciferol supplementation and dual vitamin Dtherapy in haemodialysis patients / S.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
